Thu, Nov 28, 2024
Dr. Reddy's Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal carcinoma (NPC) -- a rare and aggressive form of head and neck cancer that originates in the nasopharynx, the upper part of the throat.
More >
Wed, Nov 27, 2024
Beta Drugs on Wednesday announced Healthquad Fund II, a Singapore-based investment fund and a private wealth management firm, has picked up a minority stake in the oncology-focused formulations company by investing Rs 117 crore.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
